JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263382

Human TDP2 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

TDP2 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon1 and Insertion of the selection cassette in exon1.

View Alternative Names

5'-Tyr-DNA phosphodiesterase, 5'-tyrosyl-DNA phosphodiesterase, AD 022, EAP 2, EAP II, ETS1-associated protein 2, ETS1-associated protein II, MGC111021, MGC9099, RP1-30M3.3, TRAF and TNF receptor-associated protein, TTRAP, TYDP2_HUMAN, Tyr-DNA phosphodiesterase 2, Tyrosyl-DNA phosphodiesterase 2, dJ30M3.3

2 Images
Sanger Sequencing - Human TDP2 knockout HeLa cell lysate (AB263382)
  • Sanger seq

Unknown

Sanger Sequencing - Human TDP2 knockout HeLa cell lysate (AB263382)

Allele-2 : Insertion of the selection cassette in exon1

Sanger Sequencing - Human TDP2 knockout HeLa cell lysate (AB263382)
  • Sanger seq

Unknown

Sanger Sequencing - Human TDP2 knockout HeLa cell lysate (AB263382)

Allele-1 : 2 bp deletion in exon1

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon1 and Insertion of the selection cassette in exon1.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263382-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human TDP2 knockout HeLa cell lysate", "number":"AB263382-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB263382-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
TDP2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TDP2 also known as Tyrosyl-DNA phosphodiesterase 2 functions mechanically by repairing DNA through removing topoisomerase II-DNA adducts. It has a mass of approximately 53 kDa. TDP2 shows expression in various tissues with notable levels in brain and muscle. The enzyme exhibits phosphodiesterase activity which is essential for resolving stalled topoisomerase-2-mediated breaks during the repair process.
Biological function summary

TDP2 plays an important role in DNA repair mechanisms. It participates in excising 5'-phosphotyrosyl moieties linked to DNAn important for maintaining genomic stability. TDP2 does not work as a part of a large protein complex but its activity supports several cellular processes by ensuring proper DNA repair. It facilitates the release of covalent protein-DNA complexes therefore aiding cell survival and function.

Pathways

TDP2 contributes to the DNA damage response and repair pathways. It acts in concert with proteins like XRCC1 and PARP1 to ensure repair of DNA strand breaks. Additionally TDP2 is involved in the non-homologous end joining (NHEJ) pathway an important mechanism for repairing double-strand breaks. Its function complements topoisomerase-related activities maintaining genomic integrity during cell division.

TDP2 has been connected to neurodegenerative diseases and certain cancers. Mutations or dysfunctions in TDP2 can lead to spinocerebellar ataxia and intellectual disability as the enzyme’s role in DNA repair is compromised. In cancer disruptions in TDP2 activity can influence cancer progression with interactions involving proteins like ATM playing a role in oncogenesis. Understanding these relationships highlights potential therapeutic targets for treatment strategies.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com